x

Rechercher un essai clinique

* (*) Champ obligatoire

55 Résultat(s)

Trier par

Essai en cours de recrutement = Essai en cours de recrutement; Essai en cours = Essai en cours; Financé par un membre IRDiRC =

Essai(s) clinique(s) national(aux)

ALLEMAGNE

Baden-Württemberg
TÜBINGEN

A randomized, double-blind, placebo-controlled, parallel group phase II study to evaluate the safety and efficacy of AFQ056 in adult patients with Fragile X Syndrome - DE - Completed
Universitätsklinik für Psychiatrie und Psychotherapie
Abteilung Psychiatrie und Psychotherapie im Kindes- und Jugendalter

CANADA

Québec
MONTRÉAL

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate AFQ056 in Adult Patients With Fragile X Syndrome (phase IIb) (Completed) - CA
Centre hospitalier universitaire Sainte-Justine
Centre de recherche - Centre hospitalier universitaire Saint-Justine

ETATS-UNIS

Ohio
CINCINNATI

Essai en cours de recrutementEssai en coursFinancé par un membre IRDiRCQuercetin in Children With Fanconi Anemia; a Pilot Study (Phase 1/2) - US
Cincinnati Children's Hospital Medical Center
Department of Pediatry

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

FRANCE

OCCITANIE
TOULOUSE

ITALIE

LAZIO
ROMA

Essai en cours de recrutementEssai en coursA Phase 1/2 Study of ARQ 092 in Patients with Overgrowth Diseases and/or Vascular Anomalies with Genetic Alterations of the PI3K/AKT Pathway
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
Ambulatorio Polispecialistico per le Malattie Rare

ROYAUME-UNI

Merseyside
LIVERPOOL

Essai en coursEffects of exenatide on appetite and ghrelin levels in patients with Prader-Willi Syndrome
Fazakerley Hospital
University Hospital Aintree - Diabetes and Endocrinology

ROYAUME-UNI

West Midlands
BIRMINGHAM

Essai(s) clinique(s) multinational(aux)

ESPAGNE

Madrid
MADRID

Essai en coursFinancé par un membre IRDiRCEUROFANCOLEN: Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action
CIEMAT - Centro de Investigaciones Energéticas Medioambientales y Tecnológicas
Terapias innovadoras en el sistema hematopoyético